208 related articles for article (PubMed ID: 34592153)
21. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.
Gumucio DL; Rood KL; Gray TA; Riordan MF; Sartor CI; Collins FS
Mol Cell Biol; 1988 Dec; 8(12):5310-22. PubMed ID: 2468996
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster.
de Andrade TG; Peterson KR; Cunha AF; Moreira LS; Fattori A; Saad ST; Costa FF
Blood Cells Mol Dis; 2006; 37(2):82-90. PubMed ID: 16952470
[TBL] [Abstract][Full Text] [Related]
23. HMG-I binds to GATA motifs: implications for an HPFH syndrome.
Magis W; Martin DI
Biochem Biophys Res Commun; 1995 Sep; 214(3):927-33. PubMed ID: 7575565
[TBL] [Abstract][Full Text] [Related]
24. Fetal Hemoglobin Regulation in Beta-Thalassemia.
Lu HY; Orkin SH; Sankaran VG
Hematol Oncol Clin North Am; 2023 Apr; 37(2):301-312. PubMed ID: 36907604
[TBL] [Abstract][Full Text] [Related]
25. An erythroid-specific DNA binding factor mediates increased gamma-globin expression in hereditary persistence of fetal hemoglobin (HPFH).
Martin DI; Orkin SH
Prog Clin Biol Res; 1989; 316A():217-28. PubMed ID: 2480608
[No Abstract] [Full Text] [Related]
26. Purification and identification of proteins that bind to the hereditary persistence of fetal hemoglobin -198 mutation in the gamma-globin gene promoter.
Olave IA; Doneanu C; Fang X; Stamatoyannopoulos G; Li Q
J Biol Chem; 2007 Jan; 282(2):853-62. PubMed ID: 17114178
[TBL] [Abstract][Full Text] [Related]
27. DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin.
Ottolenghi S; Mantovani R; Nicolis S; Ronchi A; Giglioni B
Hemoglobin; 1989; 13(6):523-41. PubMed ID: 2481658
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
29. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy.
Ikuta T; Kan YW; Swerdlow PS; Faller DV; Perrine SP
Blood; 1998 Oct; 92(8):2924-33. PubMed ID: 9763579
[TBL] [Abstract][Full Text] [Related]
30. A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin.
Berry M; Grosveld F; Dillon N
Nature; 1992 Aug; 358(6386):499-502. PubMed ID: 1379347
[TBL] [Abstract][Full Text] [Related]
31. The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.
Fischer KD; Nowock J
Nucleic Acids Res; 1990 Oct; 18(19):5685-93. PubMed ID: 1699206
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
[TBL] [Abstract][Full Text] [Related]
33. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
[TBL] [Abstract][Full Text] [Related]
34. A naturally occurring gamma globin gene mutation enhances SP1 binding activity.
Sykes K; Kaufman R
Mol Cell Biol; 1990 Jan; 10(1):95-102. PubMed ID: 1688466
[TBL] [Abstract][Full Text] [Related]
35. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
Rixon MW; Gelinas RE
Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
[TBL] [Abstract][Full Text] [Related]
36. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of hereditary persistence of fetal hemoglobin.
Forget BG
Ann N Y Acad Sci; 1998 Jun; 850():38-44. PubMed ID: 9668525
[TBL] [Abstract][Full Text] [Related]
38. An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.
Tanabe O; Katsuoka F; Campbell AD; Song W; Yamamoto M; Tanimoto K; Engel JD
EMBO J; 2002 Jul; 21(13):3434-42. PubMed ID: 12093744
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a globin promoter-specific silencer element located upstream of the human delta-globin gene.
Vitale M; Di Marzo R; Calzolari R; Acuto S; O'Neill D; Bank A; Maggio A
Biochem Biophys Res Commun; 1994 Oct; 204(1):413-8. PubMed ID: 7524502
[TBL] [Abstract][Full Text] [Related]
40. Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobin.
Ronchi A; Berry M; Raguz S; Imam A; Yannoutsos N; Ottolenghi S; Grosveld F; Dillon N
EMBO J; 1996 Jan; 15(1):143-9. PubMed ID: 8598197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
